Effects of subinhibitory concentrations of menthol on adaptation, morphological, and gene expression changes in enterohemorrhagic Escherichia coli

Applied and Environmental Microbiology

Volumn 78, Issue 15, 2012, Pages 5361-5367

  Landau, Elad ^a   Shapira, Roni ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-BACTERIAL ACTIVITY; BIOFILM FORMATION; BIOFILM PRODUCTION; COLANIC ACID; E. COLI; ENTEROHEMORRHAGIC ESCHERICHIA COLI; MORPHOLOGICAL ALTERATION; NULL MUTANT; SI CONCENTRATION;

BIOFILMS; ESCHERICHIA COLI; GENE ENCODING; SCANNING ELECTRON MICROSCOPY;

GENE EXPRESSION;

BETA GALACTOSIDASE; GREEN FLUORESCENT PROTEIN; MENTHOL;

ADAPTATION; ALCOHOL; ANTIMICROBIAL ACTIVITY; BACTERIOLOGY; BIOFILM; COLONY; CONCENTRATION (COMPOSITION); FECAL COLIFORM; GENE EXPRESSION; INHIBITOR; MORPHOLOGY; VIRULENCE;

ADAPTATION; ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; DRUG EFFECT; ENTEROHEMORRHAGIC ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETICS; MICROBIAL SENSITIVITY TEST; PATHOGENICITY; PHYSIOLOGY; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE; VIRULENCE;

ADAPTATION, BIOLOGICAL; BETA-GALACTOSIDASE; BIOFILMS; DRUG RESISTANCE, BACTERIAL; ENTEROHEMORRHAGIC ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GREEN FLUORESCENT PROTEINS; MENTHOL; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; VIRULENCE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84866158242     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00894-12     Document Type: Article

References (50)

1. Allen KJ, Lepp D, McKellar RC, Griffiths MW. 2008. Examination of stress and virulence gene expression in Escherichia coli O157:H7 using targeted microarray analysis. Foodborne Pathog. Dis. 5:437-447.
2. Babic F, Venturi V, Maravic-Vlahovicek G. 2010. Tobramycin at subinhibitory concentration inhibits the RhlI/R quorum sensing system in a Pseudomonas aeruginosa environmental isolate.BMCInfect. Dis. 10:148.
3. Barnhart MM, Chapman MR. 2006. Curli biogenesis and function. Annu. Rev. Microbiol. 60:131-147.
4. Bikels-Goshen T, Landau E, Saguy S, Shapira R. 2010. Staphylococcal strains adapted to epigallocathechin gallate (EGCG) show reduced susceptibility to vancomycin, oxacillin and ampicillin, increased heat tolerance, and altered cell morphology. Int. J. Food Microbiol. 138:26-31.
5. Burt S. 2004. Essential oils: their antibacterial properties and potential applications in foods-a review. Int. J. Food Microbiol. 94:223-253.
6. Cristani M, et al. 2007. Interaction of four monoterpenes contained in essential oils with model membranes: implications for their antibacterial activity. J. Agric. Food Chem. 55:6300-6308.
7. Danese PN, Pratt LA, Kolter R. 2001. Biofilm formation as a developmental process. Methods Enzymol. 336:19-26.
8. Deng W, et al. 2004. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc. Natl. Acad. Sci. U. S. A. 101:3597-3602.
9. Derakhshan S, Sattari M, Bigdeli M. 2008. Effect of subinhibitory concentrations of cumin (Cuminum cyminum L.) seed essential oil and alcoholic extract on the morphology, capsule expression and urease activity of Klebsiella pneumoniae. Int. J. Antimicrob. Agents 32:432-436.
10. Dowd SE, Killinger-Mann K, Brashears M, Fralick J. 2008. Evaluation of gene expression in a single antibiotic exposure-derived isolate of Salmonella enterica typhimurium 14028 possessing resistance to multiple antibiotics. Foodborne Pathog. Dis. 5:205-221.
11. Errington J. 1996. Determination of cell fate in Bacillus subtilis. Trends Genet. 12:31-34.
12. Ferrieres L, Aslam SN, Cooper RM, Clarke DJ. 2007. The yjbEFGH locus in Escherichia coli K-12 is an operon encoding proteins involved in exopolysaccharide production. Microbiology 153:1070-1080.
13. George JN. 2009. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989-2007). Kidney Int. Suppl. 2009:S8-S10.
14. Gerstel U, Romling U. 2003. The csgD promoter, a control unit for biofilm formation in Salmonella typhimurium. Res. Microbiol. 154:659-667.
15. Gur-Arie R, et al. 2000. Simple sequence repeats in Escherichia coli: abundance, distribution, composition, and polymorphism. Genome Res. 10: 62-71.
16. Hanna A, Berg M, Stout V, Razatos A. 2003. Role of capsular colanic acid in adhesion of uropathogenic Escherichia coli. Appl. Environ. Microbiol. 69:4474-4481.
17. Hofmann SL. 1993. Southwestern Internal Medicine Conference: Shigalike toxins in hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura. Am. J. Med. Sci. 306:398-406.
18. Hoiby N, et al. 2011. The clinical impact of bacterial biofilms. Int. J. Oral Sci. 3:55-65.
19. Iwalokun BA, et al. 2003. Effects of Ocimum gratissimum L essential oil at subinhibitory concentrations on virulent and multidrug-resistant Shigella strains from Lagos, Nigeria. APMIS 111:477-482.
20. Kunzendorf U, Karch H, Werber D, Haller H. 2011. Recent outbreak of hemolytic uremic syndrome in Germany. Kidney Int. 80:900-902.
21. Lee J, Bansal T, Jayaraman A, Bentley WE, Wood TK. 2007. Enterohemorrhagic Escherichia coli biofilms are inhibited by 7-hydroxyindole and stimulated by isatin. Appl. Environ. Microbiol. 73:4100-4109.
22. Levine MM. 1987. Escherichia coli that cause diarrhea-enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. J. Infect. Dis. 155:377-389.
23. Li J, et al. 2011. Peppermint oil decreases the production of virulenceassociated exoproteins by Staphylococcus aureus. Molecules 16:1642-1654.
24. Majdalani N, Gottesman S. 2005. The Rcs phosphorelay: a complex signal transduction system. Annu. Rev. Microbiol. 59:379-405.
25. McDaniel TK, Kaper JB. 1997. A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Mol. Microbiol. 23:399-407.
26. Mellies JL, Elliott SJ, Sperandio V, Donnenberg MS, Kaper JB. 1999. The Per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol. Microbiol. 33: 296-306.
27. Miller JH. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
28. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
29. Niu C, Afre S, Gilbert ES. 2006. Subinhibitory concentrations of cinnamaldehyde interfere with quorum sensing. Lett. Appl. Microbiol. 43:489-494.
30. Olsen A, et al. 2002. Identification of two protein-binding and functional regions of curli, a surface organelle and virulence determinant of Escherichia coli. J. Biol. Chem. 277:34568-34572.
31. Park SH, Oh KH, Kim CK. 2001. Adaptive and cross-protective responses of Pseudomonas sp. DJ-12 to several aromatics and other stress shocks. Curr. Microbiol. 43:176-181.
32. Patel T, Ishiuji Y, Yosipovitch G. 2007. Menthol: a refreshing look at this ancient compound. J. Am. Acad. Dermatol. 57:873-878.
33. Perrin C, et al. 2009. Nickel promotes biofilm formation by Escherichia coli K-12 strains that produce curli. Appl. Environ. Microbiol. 75:1723-1733.
34. Qiu J, et al. 2011. Menthol diminishes Staphylococcus aureus virulenceassociated extracellular proteins expression. Appl. Microbiol. Biotechnol. 90:705-712.
35. Qiu J, et al. 2010. Subinhibitory concentrations of thymol reduce enterotoxins A and B and alpha-hemolysin production in Staphylococcus aureus isolates. PLoS One 5:e9736. doi:10.1371/journal.pone.0009736.
36. Qiu J, et al. 2011. Subinhibitory concentrations of perilla oil affect the expression of secreted virulence factor genes in Staphylococcus aureus. PLoS One 6:e16160. doi:10.1371/journal.pone.0016160.
37. Rangel JM, Sparling PH, Crowe C, Griffin PM, Swerdlow DL. 2005. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg. Infect. Dis. 11:603-609.
38. Sailer FC, Meberg BM, Young KD. 2003. Β-Lactam induction of colanic acid gene expression in Escherichia coli. FEMS Microbiol. Lett. 226:245-249.
39. Schelz Z, Molnar J, Hohmann J. 2006. Antimicrobial and antiplasmid activities of essential oils. Fitoterapia 77:279-285.
40. Shapira R, Mimran E. 2007. Isolation and characterization of Escherichia coli mutants exhibiting altered response to thymol. Microb. Drug Resist. 13:157-165.
41. Sledjeski DD, Gottesman S. 1996. Osmotic shock induction of capsule synthesis in Escherichia coli K-12. J. Bacteriol. 178:1204-1206.
42. Smith-Palmer A, Stewartt J, Fyfe L. 2002. Inhibition of listeriolysin O and phosphatidylcholine-specific production in Listeria monocytogenes by subinhibitory concentrations of plant essential oils. J. Med. Microbiol. 51:567-574.
43. Tobe T, et al. 2005. Dual regulatory pathways integrating the RcsC-RcsDRcsB signalling system control enterohaemorrhagic Escherichia coli pathogenicity. Mol. Microbiol. 58:320-333.
44. Trombetta D, et al. 2005. Mechanisms of antibacterial action of three monoterpenes. Antimicrob. Agents Chemother. 49:2474-2478.
45. Ultee A, Bennik MH, Moezelaar R. 2002. The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl. Environ. Microbiol. 68:1561-1568.
46. Ultee A, Kets EP, Alberda M, Hoekstra FA, Smid EJ. 2000. Adaptation of the food-borne pathogen Bacillus cereus to carvacrol. Arch. Microbiol. 174:233-238.
47. Walsh SE, et al. 2003. Development of bacterial resistance to several biocides and effects on antibiotic susceptibility. J. Hosp. Infect. 55:98-107.
48. Wortinger MA, Quardokus EM, Brun YV. 1998. Morphological adaptation and inhibition of cell division during stationary phase in Caulobacter crescentus. Mol. Microbiol. 29:963-973.
49. Young KD. 2007. Bacterial morphology: why have different shapes" Curr. Opin. Microbiol. 10:596-600.
50. Zuber M, Hoover TA, Court DL. 1995. Analysis of a Coxiella burnetti gene product that activates capsule synthesis in Escherichia coli: requirement for the heat shock chaperone DnaK and the two-component regulator RcsC. J. Bacteriol. 177:4238-4244.